Skip to main content

Caffeine Citrate Injection Shortage

Last Updated: May 26, 2016
Status: Resolved

Products Affected - Description
    • Caffeine Citrate injection, Caraco, 20 mg/mL, 3 mL 1 count, NDC 47335-0289-40
Reason for the Shortage
    • Caraco temporarily discontinued caffeine citrate injection.
    • Exela Pharma Sciences launched caffeine citrate intravenous injection in mid-2015.
    • Sagent states the reason for the shortage was manufacturing delays.
    • West-Ward has Cafcit 10 count presentations available. The company is not producing the 1 count presentation at this time to focus on the 10 count presentation.
Available Products
    • Cafcit injection, West-Ward, 20 mg/mL, 3 mL vial, 10 count, NDC 00641-6164-10
    • Caffeine Citrate injection, American Regent, 20 mg/mL, 3 mL vial, 10 count, NDC 00517-0020-10
    • Caffeine Citrate injection, Exela Pharma Sciences, 20 mg/mL, 3 mL vial, 1 count, NDC 51754-0500-01
    • Caffeine Citrate injection, Fresenius Kabi, 20 mg/mL, 3 mL vial, 1 count, NDC 63323-0407-03
    • Caffeine Citrate injection, Sagent, 20 mg/mL, 3 mL 1 count, NDC 25021-0601-03

Estimated Resupply Dates

    • Caraco has temporarily discontinued caffeine citrate injection and the company cannot estimate when product will return.
    • All other marketed presentations are available.


Updated May 26, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 11, 2011 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.